Last updated on April 2017

The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis


Brief description of study

The investigators postulate that F-18 florbetapir will show improved detection of cardiac amyloidosis over conventional non-invasive imaging techniques, particularly in early disease.

Detailed Study Description

F-18 florbetapir is currently used for the early detection of brain amyloid (Alzheimer's disease). The hypothesis is that F-18 florbetapir will detect amyloid deposition in myocardium prior to current non-invasive diagnostic measures, particular electrocardiography with strain and technetium pyrophosphate scintigraphy. The investigators intend to use F-18 florbetapir and assess its correlation between standard non-invasive diagnostic modalities.

Clinical Study Identifier: NCT03040427

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Wael Jaber, M.D.

Cleveland Clinic Foundation (Main Campus)
Cleveland, OH United States
  Connect »